Long-term effectiveness and safety of deucravacitinib for psoriasis: a 52-week real-world study of genital, scalp and nail lesions
Deucravacitinib may be a promising long-term treatment option for psoriasis, demonstrating sustained effectiveness and safety, including in difficult-to-treat areas, such as the genital, scalp and nail regions in real-world clinical practice.
Authors
- Eita Fujimoto
- Naoko Kanda (ORCID: https://orcid.org/0000-0003-4389-2312)
- Hidehisa Saeki (ORCID: https://orcid.org/0000-0002-1095-0355)
- Teppei Hagino (ORCID: https://orcid.org/0000-0002-4183-9596)
Institutions
- Fujimoto Dental and Oral Surgery Clinic (JP)
- Chiba Hokusou Hospital (JP)
- Nippon Medical School (JP)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2024-12-06
- DOI
- https://doi.org/10.1093/ced/llae530
- Citations
- 12
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 2.89